fbpx

Labcorp Panels for Primary Care

Early detection supports more informed referrals

14-3-3η is clinically proven biomarker which predicts Rheumatoid Arthritis (RA) development in patients with joint pain and helps assists with early diagnosis. The 14-3-3η blood test can identify RA earlier than traditional blood tests alone, identifying 21% of early RA patients and 67% of established RA patients who test negative in RF and anti-CCP blood tests.

Labcorp Panels:

These panels are designed to stratify patients for risk of joint destruction and/or radiographic progression, and to monitor disease activity and effectiveness of treatment.

RheumAssure®

The RheumAssure® test panel includes Anti-CCP 3.1, Rheumatoid Factor (RF) and 14-3-3η for high sensitivity for both early (78-92%) and established (88-96%) RA to support accurate diagnosis.

RheumAssure®
HCP Ordering Information
Test code: 504509
Sample Report

RAdx6 Profile

The RAdx6 test panel includes RF by Turb; Anti-CCP (Cyclic Citrullinated Peptide) Ab, IgG & IgA; 14.3.3 eta; Anti-CEP1 Ab, IgG; Anti-Sa Ab; Anti-CEP1 (citrullinated alpha-enolase 1) Ab; Anti-Sa (citrullinated vimentin) Ab; Anti-CarP (carbamylated protein) Ab.

 

RAdx6
HCP Ordering Information
Test code: 520304
Sample Report

SeroNegRAdx4 Profile and RA Profile reflex to SeroNegRAx4

Diagnostic and prognostic panels designed to complement traditional RF and anti-CCP testing. The profile consists of 14-3-3η, anti-SA, anti-CEP-1, and anti-CarP. Helps identify RA in anti-CCP-negative and RF-negative patients (seronegative RA) and diagnosis of early RA.

SeroNegRAdx4 and RA Profile
reflex to SeroNegRAx4
HCP Ordering Information
Test code: 520298
Sample Report

14-3-3η stand-alone test

14-3-3η is a joint-derived, proinflammatory mediator that is implicated in the joint erosion process and pathogenesis of RA. Serum 14-3-3η is elevated in both early and established RA and serves as a diagnostic and prognostic biomarker, even in seronegative RA.

14-3-3η
HCP Ordering Information
Test code: 504550 
Sample Test Report

Publications for Health Care Providers

The 14-3-3η blood test is covered by CMS and Health Insurance providers